ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Callisto Pharmaceuticals,

Callisto Pharmaceuticals, (KAL)

0.00
0.00
( 0.00% )

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Estadísticas y detalles clave

Último Precio
-
Postura de Compra
-
Postura de Venta
-
Volume Operado de la Acción
-
0.00 Rango del Día 0.00
0.00 Rango de 52 semanas 0.00
Precio Anterior
-
Precio de Apertura
-
Hora
Última hora de negociación
-
Volumen promedio (3 m)
-
Volumen financiero
-
Precio Promedio Ponderado
-

KAL Últimas noticias

Callisto Pharmaceuticals, Inc. Receives Notice of Delisting From Amex - Subject to Appeal -

Callisto Pharmaceuticals, Inc. (AMEX: KAL), announced today that on April 7, 2008, it received notice from the American Stock Exchange indicating that AMEX intends to strike the...

Callisto Pharmaceuticals Completes Enrollment of Phase II Trial of Atiprimod in Neuroendocrine Cancer

NEW YORK, Sept. 20 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a developer of new drug treatments in the fight against cancer and gastrointestinal disorders...

American Stock Exchange Accepts Callisto Pharamceuticals' Plan of Compliance and Extension to Regain Compliance with Standards

NEW YORK, Aug. 29 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a developer of new drug treatments in the fight against cancer and gastrointestinal disorders...

Hagens Berman Sobol Shapiro: Class Action Lawsuit Filed Against Korean Air Lines

Plaintiff claims suffered damages in Korean Air Lines price fixing conspiracy SEATTLE, Aug. 10 /PRNewswire/ -- Seattle-based law firm Hagens Berman Sobol Shapiro filed a class action lawsuit...

Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients

NEW YORK, Aug. 9 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a developer of new drug treatments in the fight against cancer and inflammatory diseases...

Callisto Reports on Second-Quarter 2007 Milestones

Company Cites Continuing Progress on Clinical and Preclinical Programs NEW YORK, Aug. 8 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a developer of new drug...

Callisto Pharmaceuticals Raises $11.2 Million in Series B Preferred Stock Financing

NEW YORK, Aug. 7 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a biopharmaceutical company primarily focused on the development of new drugs to treat cancer and...

Callisto Pharmaceuticals Opens Additional Site for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients

NEW YORK, June 25 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a developer of new drug treatments in the fight against cancer and other major health threats...

Callisto Pharmaceuticals, Inc. Receives Notice From AMEX

NEW YORK, June 22 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (AMEX:KAL), a biopharmaceutical company primarily focused on the development of new drugs to treat cancer and...

Callisto Pharmaceuticals Files Suit Against Former Executive Vice President for Breach of Employment Agreement, Fraud, Conversio

NEW YORK, June 8 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a biopharmaceutical company focused on the development of new drugs to treat cancer and...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
OSTXOS Therapies Incorporated
US$ 2.595
(24.91%)
80.69k
KAPAKairos Pharma Ltd
US$ 1.62
(17.39%)
144.08k
YANGDirexion Daily FTSE China Bear 3X Shares New
US$ 64.33
(12.07%)
1.67M
GPUSHyperscale Data Inc
US$ 7.355
(10.94%)
83.04k
GOOXT Rex 2x Long Alphabet Daily Target ETF
US$ 35.37
(10.29%)
91.47k
MGLDMarygold Companies Inc
US$ 1.23
(-16.89%)
343
CHROChannel Therapeutics Corporation
US$ 0.60
(-15.07%)
127.05k
MYNDMynd ai Inc
US$ 2.2899
(-13.59%)
102.46k
YINNDirexion Daily FTSE China Bull 3X Shares
US$ 31.55
(-12.14%)
10.4M
CRFCornerstone Total Return Fund New
US$ 8.16
(-11.50%)
5.2M
MSTZT Rex 2X Inverse MSTR Daily Target ETF
US$ 1.065
(-2.29%)
194.68M
SOXLDirexion Daily Semiconductor Bull 3X Shares
US$ 27.2084
(-6.92%)
49.12M
FXIiShares China Large Cap
US$ 31.88
(-4.26%)
37.9M
NVDQT Rex 2X Inverse NVIDIA Daily Target ETF
US$ 3.4572
(3.98%)
37.32M
SLViShares Silver Trust
US$ 29.20
(0.76%)
30.22M
georgie18 georgie18 5 minutos hace
ALCE...$1.16...🥳...Psar flipped Bullish...

georgie18

Member Level
Re: georgie18 post# 44

Tuesday, December 10, 2024 11:53:04 AM

Post#
45
of 45
ALCE...$1.10...added here...🥳

georg
ALCE
Ms Labonte Ms Labonte 6 minutos hace
Big momma going to $lap bitche$$$
LAP
Bigfootbud Bigfootbud 6 minutos hace
isn't it illegal to purposely manipulate stocks like that?
RDAR
georgie18 georgie18 6 minutos hace
Yes I agree...been holding mine for years ...🥳
BullNBear52 BullNBear52 6 minutos hace
Wasn't so long ago where $250M for 10 years was the norm. Now with Soto it's 3 times that much. The only way to stop the insanity is with a salary cap like all the other professional sports have.

Until then guys like Cohen can spend as much as he wants realizing that any money the Me
Lone Clone Lone Clone 6 minutos hace
AERO ENERGY AND FORTUNE BAY TO ADVANCE EXPLORATION AT THE MURMAC URANIUM PROJECT

Follow-up to the high-grade uranium intersected during the summer 2024 drill program

https://www.newswire.ca/news-releases/aero-energy-and-fortune-bay-to-advance-exploration-at-the-murmac
Ms Labonte Ms Labonte 6 minutos hace
Drop your pant$$ fill em bid$$$
RNAZ
firebag1 firebag1 7 minutos hace
going up!
HMBL
Oleblue Oleblue 7 minutos hace
Some people push a stock with multiple postings every day which gets old in a hurry.
It is best to put them on ignore.

Go to the Quantum World Congress 2024 and look at some of the videos:

https://youtu.be/eRsCOWBZlxE?list=PLqMDXDxb_hzLcgwY2_xMpfUanIWSclTxV
IONQ
BoscoLives21 BoscoLives21 7 minutos hace
LOL! But all jokes aside, it’s just a matter of time here, as we are now a profitable company with first rate beer and ale production continuing to increase.

https://nyibeercompetition.com/

GO $KEGS!!
KEGS
Waalrus Waalrus 7 minutos hace
😀😀😀
AHRO
RammageRaul RammageRaul 8 minutos hace
I think we will never have another 2021 that was our opportunity to become millionaires lol
Glad to be here for the mega bounce $$$
HMBL
HMBL
koolmc koolmc 8 minutos hace
not in that but been following it, not much time left in the month now only few weeks left
EEGI
JERSEYHAWG JERSEYHAWG 8 minutos hace
HEADS UP HERE....PAY ATTENTION.....TO THOSE WHO HAD STOCK MOVED TO SCHAWB......

I just hot a email from Schwab...for in active stock...they WERE GOING TO REMOVE IT..they gave a cusip and share count.

So. I called Schwab and asked them to tell me which stock it was. Lol
LEHNQ
m$teamworkotc m$teamworkotc 8 minutos hace
break 0011
lets goooooo close this green
HMBL
Invest-in-America Invest-in-America 9 minutos hace
GXAI: Wake-up, GXAI stock!! (Hope ya ain't tryin' to do the old Wall Street, " DEAD-CAT-BOUNCE " routine --- like depicted below!!!)

https://i.giphy.com/media/v1.Y2lkPTc5MGI3NjExNG0zNWR0cW80Z3A1MXN4MDUxeHIydTV2eHA2ZHN0azV6NHZ0cTV5NSZlcD12MV9pbnRlcm5hbF9naWZfYnlfaWQmY3Q9Zw/AENsvgBlIhts
GXAI
Noghawbuck Noghawbuck 9 minutos hace
Ben Grinch taking Christmas from shareholders agin this year !
FUNN
ccie1024 ccie1024 9 minutos hace
Delgocitinib approved By MHRA

Granted in 59 days using IRP via EMA.

https://www.gov.uk/government/news/delgocitinib-approved-to-treat-adult-patients-with-severe-chronic-hand-eczema
NWBO
jimr1717 jimr1717 9 minutos hace
Humbled
HMBL
sharkey1 sharkey1 9 minutos hace
Just a thought, The quota for Vyvanse should be top tier, given the new allotments for the generics, and Takeda.
and Elite already has a proven track record for selling ADHD drugs on the market. Don't know what it takes
to launch 7 strengths, what's expected, If they can't use the n
ELTP
jimr1717 jimr1717 10 minutos hace
Stumbling
HMBL
James salmon James salmon 10 minutos hace
For some reason had problem posting last few days, finally back up. We'll good to see some movement and news coming out. Just a couple of things to note. 

Good to see we are going to get a conference call with next earnings.

Also would love to see some insider buying, w
NXPL
Chumba Wumba Chumba Wumba 10 minutos hace
Dear Imafan: first it goes up…and then goes down. Like it has done a hundred thousand times. I know it is oil well speculation…however those with stock investment demand a little more information on the current state than they have produced over the past 20 years. They don’t need “fan boys” on this
ZNOG

Su Consulta Reciente

Delayed Upgrade Clock